RegenXBio's total assets for Q4 2024 were $465.99M, a decrease of -10.23% from the previous quarter. RGNX total liabilities were $206.34M for the fiscal quarter, a -5.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.